|
|
|
Volumn 4, Issue 5, 1999, Pages 432-
|
|
Onyx plans phase III trial of ONYX-015 for head & neck cancer.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOVIRUS;
ARTICLE;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GENETICS;
HEAD AND NECK TUMOR;
HUMAN;
PHASE 3 CLINICAL TRIAL;
UNITED STATES;
ADENOVIRIDAE;
CLINICAL TRIALS, PHASE III;
GENE THERAPY;
HEAD AND NECK NEOPLASMS;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0032665398
PISSN: 10837159
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|